Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01584518 · ClinicalTrials.gov registry record · NA
B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading
A NA study, sponsored by Creighton University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01584518: Completed NA study, sponsored by Creighton University.
NCT01584518 is a NA study that has completed, run by Creighton University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01584518, a NA study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The long-range goal of this proposal is to decrease morbidity and mortality related to pulmonary edema and congestive heart failure (CHF) in post-operative patients. The short-range goal is to determine a mechanistic endpoint when therapy for impending heart failure can be initiated and terminated based on B-type natriuretic peptide (BNP) levels. The investigators propose to utilize changing levels of BNP as a surrogate marker for CHF.
Primary Outcome
The subjects will be evaluated preoperatively and followed post-operatively until discharge from the hospital. Length of stay
Interventions
- DRUG Furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT01584518 record still lists
NCT01584518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Furosemide is the first listed.
NCT01584518 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01584518 about?
NCT01584518 is a clinical study titled "B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading". The long-range goal of this proposal is to decrease morbidity and mortality related to pulmonary edema and congestive heart failure (CHF) in post-operative patients. The short-range goal is to determine a mechanistic endpoint when therapy for impending heart failure can be initiated and terminated b...
What is the current status of trial NCT01584518?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2012-07. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01584518?
The interventions under investigation include: Furosemide (DRUG).
Who is sponsoring clinical trial NCT01584518?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01584518's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia